Ignacio Inglessis-Azuaje, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foramen Ovale, Patent | 11 | 2021 | 210 | 1.150 |
Why?
|
| Aortic Diseases | 2 | 2016 | 742 | 0.560 |
Why?
|
| Vascular Fistula | 1 | 2016 | 50 | 0.530 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2004 | 72 | 0.500 |
Why?
|
| Catheterization | 10 | 2011 | 1431 | 0.480 |
Why?
|
| Mitral Valve Stenosis | 6 | 2013 | 342 | 0.410 |
Why?
|
| Heart Valve Diseases | 3 | 2016 | 1031 | 0.410 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2023 | 1414 | 0.390 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2023 | 1568 | 0.390 |
Why?
|
| Coronary Stenosis | 4 | 2015 | 802 | 0.360 |
Why?
|
| Embolism, Paradoxical | 3 | 2021 | 55 | 0.330 |
Why?
|
| Heart Diseases | 2 | 2016 | 2819 | 0.330 |
Why?
|
| Aortic Valve | 3 | 2016 | 1970 | 0.320 |
Why?
|
| Thrombophilia | 3 | 2021 | 306 | 0.320 |
Why?
|
| Septal Occluder Device | 4 | 2020 | 125 | 0.270 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2009 | 1724 | 0.270 |
Why?
|
| Valsalva Maneuver | 1 | 2004 | 99 | 0.220 |
Why?
|
| Stroke | 9 | 2021 | 9742 | 0.220 |
Why?
|
| Heart Defects, Congenital | 3 | 2009 | 4713 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 2 | 2013 | 1597 | 0.200 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 990 | 0.180 |
Why?
|
| Hemodynamics | 7 | 2016 | 4199 | 0.180 |
Why?
|
| Nitroimidazoles | 2 | 1998 | 118 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 362 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2023 | 580 | 0.160 |
Why?
|
| Stents | 4 | 2023 | 3201 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 4 | 2016 | 2034 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 711 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 644 | 0.150 |
Why?
|
| Device Removal | 1 | 2023 | 643 | 0.150 |
Why?
|
| Embolism | 2 | 2020 | 401 | 0.150 |
Why?
|
| Mitral Valve | 4 | 2023 | 1474 | 0.150 |
Why?
|
| Pacemaker, Artificial | 1 | 2023 | 828 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 4 | 2020 | 877 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2016 | 353 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2007 | 2894 | 0.140 |
Why?
|
| Treatment Outcome | 24 | 2023 | 65365 | 0.140 |
Why?
|
| Endocardium | 1 | 2017 | 249 | 0.130 |
Why?
|
| Atherectomy, Coronary | 2 | 2009 | 138 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2143 | 0.120 |
Why?
|
| Aortography | 1 | 2016 | 422 | 0.120 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 592 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2016 | 1095 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 3541 | 0.110 |
Why?
|
| Heart Transplantation | 3 | 2017 | 3300 | 0.110 |
Why?
|
| Coronary Angiography | 6 | 2015 | 4537 | 0.110 |
Why?
|
| Heart Rate | 2 | 2006 | 4218 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2015 | 308 | 0.100 |
Why?
|
| Drug-Eluting Stents | 2 | 2016 | 681 | 0.100 |
Why?
|
| Aneurysm | 1 | 2015 | 343 | 0.100 |
Why?
|
| Echocardiography | 7 | 2023 | 5044 | 0.090 |
Why?
|
| Middle Aged | 33 | 2021 | 223463 | 0.090 |
Why?
|
| Coronary Circulation | 2 | 2015 | 1617 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2016 | 614 | 0.090 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2004 | 452 | 0.090 |
Why?
|
| Vascular Resistance | 1 | 2013 | 940 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2010 | 131 | 0.080 |
Why?
|
| Humans | 53 | 2023 | 768298 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 1112 | 0.080 |
Why?
|
| Male | 37 | 2023 | 364870 | 0.080 |
Why?
|
| Heart-Lung Transplantation | 1 | 2009 | 87 | 0.080 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2009 | 64 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2017 | 2389 | 0.070 |
Why?
|
| Myocardium | 2 | 2017 | 4788 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2009 | 216 | 0.070 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 6566 | 0.070 |
Why?
|
| Female | 37 | 2023 | 397050 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2009 | 3681 | 0.070 |
Why?
|
| Rheumatic Heart Disease | 1 | 2008 | 164 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 1515 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1945 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.070 |
Why?
|
| Follow-Up Studies | 11 | 2016 | 39405 | 0.070 |
Why?
|
| Coronary Artery Bypass | 2 | 2006 | 2194 | 0.070 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2007 | 164 | 0.070 |
Why?
|
| Diltiazem | 1 | 2006 | 132 | 0.070 |
Why?
|
| Coronary Vasospasm | 1 | 2006 | 81 | 0.070 |
Why?
|
| Heart Septal Defects | 1 | 2007 | 191 | 0.060 |
Why?
|
| Collateral Circulation | 1 | 2007 | 291 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.060 |
Why?
|
| Recurrence | 4 | 2020 | 8501 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2023 | 54921 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6808 | 0.060 |
Why?
|
| Adult | 20 | 2023 | 223622 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2006 | 332 | 0.060 |
Why?
|
| Lipoma | 1 | 2007 | 296 | 0.060 |
Why?
|
| Aortic Coarctation | 1 | 2007 | 278 | 0.060 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 38 | 0.060 |
Why?
|
| Electrocardiography | 4 | 2006 | 6409 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2008 | 829 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2009 | 780 | 0.060 |
Why?
|
| Hospital Mortality | 6 | 2017 | 5367 | 0.060 |
Why?
|
| Sick Sinus Syndrome | 1 | 2023 | 51 | 0.060 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2008 | 577 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20766 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2008 | 777 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 374 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 11515 | 0.050 |
Why?
|
| Parasympathetic Nervous System | 1 | 2004 | 144 | 0.050 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2023 | 56 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1320 | 0.050 |
Why?
|
| Prostheses and Implants | 2 | 2007 | 1279 | 0.050 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 594 | 0.050 |
Why?
|
| Acute Disease | 3 | 2004 | 7242 | 0.050 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 997 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2012 | 2763 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2971 | 0.050 |
Why?
|
| Aged | 19 | 2023 | 171544 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1169 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 2 | 2006 | 1525 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2017 | 223 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3438 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 59683 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 15939 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 419 | 0.040 |
Why?
|
| Risk Assessment | 7 | 2011 | 24316 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.040 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 396 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1226 | 0.040 |
Why?
|
| Tyrosine | 1 | 2003 | 1428 | 0.040 |
Why?
|
| Trypanosomiasis | 1 | 1998 | 8 | 0.040 |
Why?
|
| Heparin | 1 | 2006 | 1636 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1882 | 0.040 |
Why?
|
| Tuberous Sclerosis | 1 | 2007 | 1042 | 0.040 |
Why?
|
| Proteomics | 1 | 2012 | 3906 | 0.040 |
Why?
|
| Equipment Design | 1 | 2007 | 3529 | 0.040 |
Why?
|
| Microcirculation | 1 | 2003 | 1282 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8562 | 0.040 |
Why?
|
| Inpatients | 1 | 2010 | 2569 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 2006 | 3125 | 0.040 |
Why?
|
| Homocysteine | 1 | 2021 | 637 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2020 | 1476 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2948 | 0.040 |
Why?
|
| Venezuela | 1 | 1997 | 73 | 0.040 |
Why?
|
| Time Factors | 7 | 2016 | 40267 | 0.040 |
Why?
|
| Trypanocidal Agents | 1 | 1997 | 40 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 1410 | 0.040 |
Why?
|
| Dyspnea | 1 | 2004 | 1351 | 0.030 |
Why?
|
| Myocarditis | 1 | 2004 | 803 | 0.030 |
Why?
|
| Heart | 2 | 2012 | 4449 | 0.030 |
Why?
|
| Utilization Review | 1 | 2017 | 384 | 0.030 |
Why?
|
| Atrial Fibrillation | 2 | 2009 | 5168 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2009 | 2776 | 0.030 |
Why?
|
| Retrospective Studies | 10 | 2016 | 81768 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 1997 | 246 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 1997 | 204 | 0.030 |
Why?
|
| Logistic Models | 3 | 2017 | 13323 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11914 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1997 | 591 | 0.030 |
Why?
|
| Cardiac Tamponade | 2 | 2008 | 175 | 0.030 |
Why?
|
| Survival Rate | 4 | 2013 | 12870 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 3942 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2009 | 2281 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2201 | 0.030 |
Why?
|
| United States | 5 | 2017 | 73144 | 0.030 |
Why?
|
| Anticoagulants | 3 | 2021 | 4842 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 4782 | 0.020 |
Why?
|
| Heart Failure | 1 | 2016 | 11860 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 989 | 0.020 |
Why?
|
| Quality of Life | 2 | 2023 | 13499 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36849 | 0.020 |
Why?
|
| Age Factors | 3 | 2016 | 18472 | 0.020 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2009 | 44 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13646 | 0.020 |
Why?
|
| Spain | 1 | 2011 | 492 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 23629 | 0.020 |
Why?
|
| Adolescent | 4 | 2017 | 89182 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 997 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2009 | 70 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1955 | 0.020 |
Why?
|
| Phlebography | 1 | 2009 | 326 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8051 | 0.020 |
Why?
|
| Risk Factors | 5 | 2016 | 74954 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 12557 | 0.020 |
Why?
|
| Young Adult | 4 | 2017 | 60048 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2011 | 6001 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2007 | 318 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22292 | 0.020 |
Why?
|
| Angiomyolipoma | 1 | 2007 | 188 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2005 | 475 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2877 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2009 | 1575 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 692 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 899 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2007 | 594 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 754 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1195 | 0.010 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 672 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6516 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10588 | 0.010 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 273 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1131 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14736 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15455 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2006 | 630 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2002 | 220 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2003 | 769 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2007 | 1479 | 0.010 |
Why?
|
| Hypotension | 1 | 2006 | 889 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 956 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 1375 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2009 | 6350 | 0.010 |
Why?
|
| Child | 2 | 1998 | 80894 | 0.010 |
Why?
|
| Chest Pain | 1 | 2006 | 1099 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9681 | 0.010 |
Why?
|
| Reoperation | 1 | 2009 | 4340 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5311 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 4834 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6541 | 0.010 |
Why?
|
| Boston | 1 | 2010 | 9371 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2012 | 41791 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8902 | 0.010 |
Why?
|
| Sex Factors | 1 | 2011 | 10656 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 6993 | 0.010 |
Why?
|
| Animals | 2 | 1998 | 169322 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 36512 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 42654 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 30198 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 4273 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10377 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 13019 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21544 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 4301 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 9063 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 5926 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 13050 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 27452 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 15652 | 0.000 |
Why?
|